Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPH - Cytoclonal Pharmaceutics -- Ignore unavailable to you. Want to Upgrade?

To: Doug Coughlan who wrote (215)	6/30/1998 11:50:00 PM
From: TokyoMex	Respond to of 428

Regardless ,, it seems terribly over sold ..

To: Doug Coughlan who wrote (215)	7/1/1998 3:13:00 AM
From: Axxel	Read Replies (2) \| Respond to of 428

There isn't a recommendation I know of that doesn't have some bias. If you want the report call ol' Jeff and see what in the report you may agree with, what in the report you disagree with and who know..maybe everyone can learn something. As far as the firm owning 40%, it looks as if that relationship is not hidden from anyone, but at least it puts out the fundamental rationales for everyone to see and to agree with or disagree with. It's Josh Moser. As far as Janssen/Meyers being a "legiitmate" firm, please note the firm does not make a market in CYPH to avoid potential conflicts and also note that you can get a history of the firm's regulatory history from the NASDR web site...I don't thinkyou will find the firm to be Jesse James and his gang and if you check out Bloomberg, you wil find recommendations on many large cap stocks such as John Deere, Volkswagen, SAP AG [the "Microsoft" of Europe], Intel [ a sell], K-Tel [a sell], Oxford Health [a sell]...with only 1% of the brokerage firms ever issuing a sell, I think Janssen/Meyers has a lot more "legitimacy" than you think. Are they perfect? Are you? Am I?The key is that they "try" to be and that is good enuf for me. Best personal regards...